LUXEMBOURG (AFP) — Fränk Schleck, who tested positive for the banned diuretic Xipamide during the 2012 Tour de France, continued to protest his innocence on Wednesday before the Luxembourg Anti-Doping Agency (ALAD).
“I again said that I was not at fault. The investigation continues but is not over,” Schleck told AFP following a UCI-supervised ALAD Disciplinary Committee hearing lasting more than two hours.
It was his third hearing in the case. The first took place on August 29.
A second interview took place on October 15. In that second hearing, Schleck’s roommate and RadioShack-Nissan teammate Maxime Monfort spoke in his defense.
The ALAD made no statement Wednesday on the outcome of the latest hearing.
The elder of the Schleck brothers submitted a positive doping control after the 13th stage of the Tour, on July 14, at Cap d’Agde. He left the race on the second rest day, in Pau, while ranked 12th in the overall standings.
Schleck’s B sample was positive for the diuretic, which can be used for weight loss or as a masking agent. He has said that he believes he was poisoned or accidently ingested the banned substance.
Schleck faces a two-year ban if the ALAD rules that he intentionally doped. He could see an abbreviated sentence if the agency rules that he was victim of accidental ingestion, though the UCI may appeal a shortened sanction to the Court of Arbitration for Sport.